Clinical course of Graves’ orbitopathy in children with newly diagnosed hyperthyroidism: a prospective observational study

OBJECTIVES: Although Graves' orbitopathy (GO) in childhood is generally considered milder than in adults, data regarding its clinical course and relationship with thyroid autoimmunity remain limited. This study aimed to evaluate the frequency and clinical characteristics of GO in pediatric patients with newly diagnosed hyperthyroidism and to assess short-term changes in ocular findings during follow-up. METHODS: In this prospective observational study, 24 children with hyperthyroidism were enrolled. All ophthalmologic examinations were performed by the same ophthalmologist. Ocular findings were assessed according to the 2021 EUGOGO criteria, and disease activity was determined using the Clinical Activity Score (CAS). Thyroid function tests and autoantibodies, including anti-thyroid peroxidase antibody, thyrotropin receptor antibody, and thyroid-stimulating immunoglobulin, were evaluated at baseline and at 6 months. Associations between clinical, biochemical, and ophthalmologic parameters were analyzed statistically. RESULTS: The mean age was 14.1 ± 3.4 years, and 75 % of patients were female. At baseline, 83.3 % had mild GO and 16.7 % had moderate-to-severe disease. CAS values were <3 at both time points in all patients, and no active orbitopathy was observed. Hertel measurements showed no significant changes during follow-up. Significant reductions in anti-thyroid peroxidase antibody, thyrotropin receptor antibody, and thyroid-stimulating immunoglobulin levels were observed at 6 months. Baseline Hertel values correlated positively with thyrotropin receptor antibody levels. Beta-blocker requirement decreased from 66.7 % at baseline to none at 6 months. Only one patient (4.2 %) showed transient progression in EUGOGO severity. CONCLUSIONS: In pediatric hyperthyroidism, GO is usually mild and inactive, with rare short-term clinical progression. Despite marked improvement in thyroid autoimmunity, ocular findings remained largely stable. These results support the generally benign course of childhood GO and emphasize the importance of detailed ophthalmologic assessment at diagnosis.

Institutions

Publication Details

Journal
Journal of Pediatric Endocrinology and Metabolism
Published
2026-05-19
DOI
https://doi.org/10.1515/jpem-2026-0095
Primary Topic
Ophthalmology and Eye Disorders
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Clinical course of Graves’ orbitopathy in children with newly diagnosed hyperthyroidism: a prospective observational study

Journal of Pediatric Endocrinology and Metabolism
Ophthalmology and Eye Disorders
article

Clinical course of Graves’ orbitopathy in children with newly diagnosed hyperthyroidism: a prospective observational study

article en

Abstract

OBJECTIVES: Although Graves' orbitopathy (GO) in childhood is generally considered milder than in adults, data regarding its clinical course and relationship with thyroid autoimmunity remain limited. This study aimed to evaluate the frequency and clinical characteristics of GO in pediatric patients with newly diagnosed hyperthyroidism and to assess short-term changes in ocular findings during follow-up. METHODS: In this prospective observational study, 24 children with hyperthyroidism were enrolled. All ophthalmologic examinations were performed by the same ophthalmologist. Ocular findings were assessed according to the 2021 EUGOGO criteria, and disease activity was determined using the Clinical Activity Score (CAS). Thyroid function tests and autoantibodies, including anti-thyroid peroxidase antibody, thyrotropin receptor antibody, and thyroid-stimulating immunoglobulin, were evaluated at baseline and at 6 months. Associations between clinical, biochemical, and ophthalmologic parameters were analyzed statistically. RESULTS: The mean age was 14.1 ± 3.4 years, and 75 % of patients were female. At baseline, 83.3 % had mild GO and 16.7 % had moderate-to-severe disease. CAS values were <3 at both time points in all patients, and no active orbitopathy was observed. Hertel measurements showed no significant changes during follow-up. Significant reductions in anti-thyroid peroxidase antibody, thyrotropin receptor antibody, and thyroid-stimulating immunoglobulin levels were observed at 6 months. Baseline Hertel values correlated positively with thyrotropin receptor antibody levels. Beta-blocker requirement decreased from 66.7 % at baseline to none at 6 months. Only one patient (4.2 %) showed transient progression in EUGOGO severity. CONCLUSIONS: In pediatric hyperthyroidism, GO is usually mild and inactive, with rare short-term clinical progression. Despite marked improvement in thyroid autoimmunity, ocular findings remained largely stable. These results support the generally benign course of childhood GO and emphasize the importance of detailed ophthalmologic assessment at diagnosis.

Journal of Pediatric Endocrinology and Metabolism
Ankara University (TR), Memorial Ankara Hospital (TR), Başkent University Hospital (TR), Ankara Bilkent City Hospital (TR)
Good health and well-being
Openalex Percentile: Top 5%
Ophthalmology and Eye Disorders
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.